12th Jan 2016 14:34
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | ALLIANCE PHARMA | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | Yes | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No | |||
An event changing the breakdown of voting rights | No | |||
Other (please specify): | NA | |||
3. Full name of person(s) subject to thenotification obligation: | River and Mercantile Asset Management LLP | |||
4. Full name of shareholder(s) (if different from 3.): | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 17/12/2015 | |||
6. Date on which issuer notified: | 17/12/2015 | |||
7. Threshold(s) that is/are crossed orreached: | 5% | |||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||||||||
GB0031030819 | 0 | 0. 00% | 24,000,000 | 24,000,000 | NA | 5.12% | NA | ||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| ||||||||||||
| Nominal | Delta | |||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
24,000,000 | 5.12% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | River and Mercantile Asset Management LLP | |
11. Number of voting rights proxy holder will ceaseto hold: | NA | |
12. Date on which proxy holder will cease to holdvoting rights: | NA | |
13. Additional information: | ||
14. Contact name: | Hamish Byrne | |
15. Contact telephone number: | +44 (0) 20 7601 6262 | |
Related Shares:
Alliance Pharma